Test Price
3,500 AED✅ Home Collection Available
CNS Tumor Targeted Gene Panel (Cancer Genomics) in UAE | 3500 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (ISO 9001:2015 Cert: INT/EGQ/2509DA/3139). Every result cross‑validated by NGS, FISH, and IHC.
- Specimen Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval for archival FFPE blocks. Collection arranged through our temperature‑controlled courier network.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation — a DHA‑licensed specialist explains the report in plain language.
- Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731. Pre‑authorization assistance before sample submission.
Test Overview & Methodology
The CNS Tumor Targeted Gene Panel is a cutting‑edge NGS‑based test that analyzes key genes for diagnosis, prognosis, and targeted therapy of central nervous system tumors. The panel integrates three complementary technologies to ensure comprehensive genomic profiling.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% Sensitivity via NGS + Orthogonal FISH/IHC validation | Often limited to single‑gene tests or small panels without orthogonal confirmation |
| Method | NGS (Next‑Generation Sequencing), FISH, IHC | May rely on older PCR or IHC only |
| Turnaround | 10 Working Days (Sample arrival by Tuesday 9:00 AM) | 15–21 working days typical |
Physician Insight & Safety Protocols
“The CNS Tumor Targeted Gene Panel provides critical genomic insights that guide therapy selection and prognosis. However, results must always be interpreted alongside imaging and clinical history. Our team ensures that every report is delivered with clear, compassionate counseling.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology (DHA Registration ID: 61713011)
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. This test does not replace ongoing clinical management. Continue all treatments as directed until your physician advises otherwise.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Not suitable for liquid biopsies. Requires FFPE tissue block with sufficient tumor content (>20% tumour nuclei). Samples with extensive necrosis or decalcification may be rejected.
- Specimen Rejection: Incomplete NGS Requisition Form 40, improper fixation, or damaged paraffin block.
- Emergency Red Flags (Seek Immediate Medical Attention): Sudden severe headache, new‑onset seizures, vision loss, limb weakness, or altered consciousness in a patient with a CNS mass — do not wait for test results.
- Contact: If symptoms develop, visit the nearest emergency department or call 998 for UAE ambulance.
Patient FAQ & Clinical Guidance
1. What is the CNS Tumor Targeted Gene Panel?
This comprehensive NGS-based test analyzes CNS tumor genes for mutations, fusions, and copy number variations. It combines Next‑Generation Sequencing, FISH, and IHC to profile actionable genetic alterations, enabling oncologists to match therapies to the specific tumour biology.
2. How should I prepare for this test?
No patient preparation is required. Your physician will provide a formalin‑fixed paraffin‑embedded tissue block along with the completed NGS Test Requisition Form (Form 40). Our logistics team will arrange temperature‑controlled courier pickup.
3. What is the cost and turnaround time?
The test costs 3,500 AED with results in 10 working days. The price includes expert pathological review, NGS, FISH, IHC, and a comprehensive clinical report. Samples must arrive by Tuesday 9:00 AM for the stated TAT. We offer direct insurance billing verification via WhatsApp.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All processes are performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | CNS Tumor Targeted Gene Panel (Cancer Genomics) |
| Price (AED) | 3,500 AED |
| Turnaround Time | 10 Working Days (Sample arrival by Tuesday 9:00 AM) |
| Sample Type / Matrix | Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block (Archival Tissue Specimen) |
| Methodology Used | Next‑Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH), Immunohistochemistry (IHC) |
| ICD-10-CM Code | C71.9 |
| LOINC Code | 93438-0 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians